■
■
■
■
Interpretation of Hepatitis B Serologic Test Results
Hepatitis B serologic testing involves measurement of several hepatitis B
virus (HBV)-specifi c antigens and antibodies. Different serologic “markers”
or combinations of markers are used to identify different phases of HBV
infection and to determine whether a patient has acute or chronic HBV
infection, is immune to HBV as a result of prior infection or vaccination, or
is susceptible to infection.
Hepatitis B surface
antigen (HBsAg):
A protein on the surface
of hepatitis B virus; it can
be detected in high levels
in serum during acute or
chronic hepatitis B virus
infection. The presence of
HBsAg indicates that the
person is infectious. The
body normally produces
antibodies to HBsAg as
part of the normal immune
response to infection.
HBsAg is the antigen used
to make hepatitis B vaccine.
Hepatitis B surface
antibody (anti-HBs):
The presence of anti-HBs
is generally interpreted as
indicating recovery and
immunity from hepatitis B
virus infection. Anti-HBs
also develops in a person
who has been successfully
vaccinated against
hepatitis B.
Total hepatitis B core
antibody (anti-HBc):
Appears at the onset
of symptoms in acute
hepatitis B and persists
for life. The presence of
anti-HBc indicates previous
or ongoing infection with
hepatitis B virus in an
undefi ned time frame.
IgM antibody to hepatitis B
core antigen (IgM anti-HBc):
Positivity indicates recent
infection with hepatitis B
virus (<6 mos). Its presence
indicates acute infection.
Tests
Results
Interpretation
HBsAg
negative
Susceptible
anti-HBc
negative
anti-HBs
negative
HBsAg
negative
Immune
due to natural infection
anti-HBc
positive
anti-HBs
positive
HBsAg
negative
Immune due to hepatitis B vaccination
anti-HBc
negative
anti-HBs
positive
HBsAg
positive
Acutely infected
anti-HBc
positive
IgM anti-HBc
positive
anti-HBs
negative
HBsAg
positive
Chronically infected
anti-HBc
positive
IgM anti-HBc
negative
anti-HBs
negative
HBsAg
negative
Interpretation unclear; four possibilities:
anti-HBc
positive
1. Resolved infection (most common)
anti-HBs
negative
2.
False-positive anti-HBc, thus susceptible
3. “Low level” chronic infection
4. Resolving acute infection
Adapted from: A Comprehensive Immunization Strategy to Eliminate Transmission of Hepatitis B
Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization
Practices. Part I: Immunization of Infants, Children, and Adolescents. MMWR 2005;54(No. RR-16).
DEPARTMENT OF HEALTH & HUMAN SERVICES
Centers for Disease Control and Prevention
Division of Viral Hepatitis
www.cdc.gov/hepatitis
6>